An Investigation Into an Objective Measure of Muscle Quality, Function and Ability
NCT ID: NCT04269291
Last Updated: 2022-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2020-06-18
2021-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Viscoelastic Properties of Lower Extremity's Muscles
NCT04289129
The Influence of Ageing on Muscle Quality
NCT01216917
Muscle Mass Loss in Critically Ill Patients.
NCT03865095
Quality of Life in Ventilator-dependant Neuromuscular Patients
NCT04652401
The Use of Computed Tomography (CT) to Measure Skeletal Muscle Quantity and Quality in Patients Receiving ECMO
NCT03269825
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The literature review identified electrical impedance myography (EIM) as a potentially objective technique to measure muscle quality and ability. Two hypotheses are proposed to test the objectivity:
The EIM measurement of passive and active muscle is not significantly different.
EIM measurements in younger and older adult volunteers is significantly different.
There is only one study visit for this study, so all study activities will occur on the same day at the Posture and Mobility Centre, Treforest or the Artificial Limb and Appliance Centre, Rookwood Hospital.
Eligibility for the study will be checked against the inclusion and exclusion criteria, including the requests to not have done heavy exercise for an hour before the measurements and also to have emptied their bladder before attending for the visit.
Any concerns will be also be addressed appropriately
Following the eligibility check, the CI will ensure the participant has read the PIS and fully understand it before obtaining informed consent.
Participants will be assigned a number in order to anonymise their data and only the main investigator will have access to this database of participants.
The following data will then be collected by the CI and written in a Case Report Form (CRF):
* Gender
* Date of birth (to ascertain age)
* Height (to calculate BMI)
* Weight (to calculate BMI)
* Waist measurement (to calculate RFM index, considered an alternative indicator of health).
* Medical history to ensure no existing neuromuscular, active arthritis or cardiac conditions or active implanted devices
* Perceived level of fitness - using the NHS scale https://www.nhs.uk/live-well/healthy-weight/bmi-calculator/ (to gauge muscle ability)
* A quantitative measurement method will be used in conjunction with a structured initial questionnaire relating to physical characteristics (e.g. height, weight, waist measurement, date of birth to indicate age and perceived level of fitness https://www.nhs.uk/live-well/healthy-weight/bmi-calculator/).
The CI will then attach electrodes to the arm of the participant and they will be asked to relax for 10 minutes.
The measurement device is an ImpediMed IMP SFB7 (CE 0129 marked) and is portable. EIM passes an imperceptible AC current (less than 1 mA) through the muscle under investigation and the impedance of that muscle is then recorded through a range of frequencies or at chosen frequencies.
Measurements of EIM of the relaxed muscles will be recorded in the CRF followed by measurements of EIM in the contracted muscle.
Electrodes will be carefully removed from the participant and they are invited to relax for a further 5 minutes and have a drink of water.
The participant's involvement in the study will end after the measurements have been taken.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* be over the age of 18
* no pre-existing neuromuscular disease
* not have an implanted cardiac device
* be well at the time of measurement
* be able to give informed consent
Exclusion Criteria
* Any existing cardiac disease (including having a pacemaker or ICD)
* Active arthritis
* Be pregnant
* Any other implanted electrical device
* Not able to give informed consent
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cardiff and Vale University Health Board
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stephanie Wentworth
Chief Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiff and Vale University Health Board.
Cardiff, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7703
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.